Clinical Trial Update: A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating FOLFOXIRI plus cetuximab versus FOLFOXIRI plus bevacizumab in colorectal cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cetuximab (cetuximab)

Snippet

Sponsor: Japan Clinical Cancer Research Organization | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN